• Deep anesthesia in adults may be associated with EEG burst suppression episodes and higher rates of postoperative complications.
Summary
Background: Deep anesthesia in adults may be associated with electroencephalographic (EEG) suppression and higher rates of postoperative complications. Little is known about the impact of anesthetic depth on shortor long-term outcomes in pediatrics. Brain activity monitoring may complement clinical signs of anesthetic depth. This prospective observational study aimed to assess the frequency and degree of profound EEG suppression using multichannel EEG in children during sevoflurane general anesthesia. Methods: Children aged 0-40 months who required general anesthesia for elective surgery were included. Continuous EEG recordings were performed starting from when anesthesia began and until recovery. Discontinuity was defined as EEG amplitude <25 uV, lasting ≥2 s, and observed in all electrodes across the scalp. Frequency, duration, and inter-event interval of discontinuity events were measured. Relationships between discontinuity events and postnatal age, endtidal sevoflurane concentration (etSEVO), and multiple clinical parameters were analyzed. Results: Discontinuity events were observed in 35/68 children, with a median duration of 10 s (95%CI: [8] [9] [10] [11] [12] ) and a median of 4 events per patient (95% CI: 2-7). Children who had discontinuity events were younger (5.5 months, 95%CI: 3.6-6.5) compared to children who did not have discontinuity events (10.2 months, 95%CI: 6.1-14); (difference between medians, 4.7 months, 95%CI: 2.3-8, P = 0.0002). Younger infants exhibited a higher number of discontinuity events, and the incidence decreased with postnatal age (r 68 = À0.53, P < 0.0001). The majority of discontinuity events were Introduction Discontinuous brain activity is an electroencephalographic (EEG) pattern defined as low amplitude (isoelectric-like) activity lasting for ≥2 s with a widespread distribution across the scalp (1) . Discontinuity is a characteristic background EEG feature seen in the healthy premature infant brain during sleep-wake cycling. As the brain matures, discontinuity gradually disappears, becoming mixed with long periods of continuous activity during active sleep-around 30 weeks of age-and almost absent during sleep by term (2) . At full-term, discontinuity is an abnormal finding, and is associated with critical illness such as encephalopathy (1, 3) or complex congenital heart surgery (4), and is associated with adverse neurological outcome (5) .
In anesthetized adults, EEG has been studied for monitoring brain activity and titration of dosing. Among adults, bursts followed by suppression are commonly observed at high anesthetic concentrations (6) . Our understanding of how anesthesia affects the pediatric EEG is more limited, specifically concerning the ontogeny of discontinuity.
EEG discontinuity during general anesthesia has been noted in passing in case reports and case series of children undergoing noncardiac surgery (7) (8) (9) (10) . Discontinuity events appear prevalent among anesthetized infants aged 0-6 months, and absent above 12 months of age (7, 8) .
Most pediatric EEG studies have been performed with a limited number of EEG channels, or with variability in types of montages and analytical methods used; few have evaluated EEG in the first year of life (7) (8) (9) (10) (11) (12) (13) (14) . Spatial and temporal aspects of discontinuity events and clinical correlates have not been studied in detail. Continuous, multichannel EEG measurements of brain activity during general anesthesia are essential to better our understanding of physiological processes in the developing brain in the context of general anesthesia.
The study aim was to analyze the incidence of discontinuity events and the association with demographic and perioperative factors in children aged 0-40 months during sevoflurane anesthesia.
Material and methods

Subjects
Children were recruited from Boston Children's Hospital (BCH) preoperative clinic from December 2012 to May 2016. Eligibility criteria included ages 0 and 40 months, American Society of Anesthesiologists' physical status I-II, and requiring surgery below the neck. Exclusion criteria were (i) congenital malformations or other genetic conditions thought to influence brain development, (ii) neurological or cardiovascular disorder, or (iii) born <32 weeks postmenstrual age.
Ethics approval was obtained from BCH Institutional Review Board. Informed written consent was obtained from parents/legal guardians. The study conformed to the Declaration of Helsinki and Good Clinical Practice guidelines.
Details of the study profile (Figure 1 ), study design (Figure 2a) , and subject demographics (Table 1) are provided.
Anesthetic management
Each child received anesthetic induction with sevoflurane AE nitrous oxide. Nitrous oxide was added at the anesthesiologist's discretion (49/68 cases). Airways were maintained using an endotracheal tube (ETT; n = 49), laryngeal mask airway (n = 14), or face mask (n = 5). Propofol was used primarily to facilitate tracheal intubation or laryngeal mask placement in 32/63 cases (median cumulative dose: 2.1 mgÁkg
À1
, 95%CI: 1.8-3.1 mgÁkg À1 ), and was administered on multiple occasions in 12/32 cases. No children were prescribed midazolam or other premedication. Details of the anesthetic management for individual subjects are provided in Table S1 .
Endtidal sevoflurane concentration (etSEVO), endtidal nitrous oxide concentration, and propofol administration were adjusted according to the anesthesiologist's impression of clinical need. The EEG monitor was positioned away from the anesthesiologist's line of sight so that they remained blinded to the EEG results during the case.
Data acquisition
EEG recording
An EEG cap (WaveGuard; Advanced NeuroTechnology, Enschede, the Netherlands) was placed on the patient before anesthesia administration started, as reported previously (14) .
A minimum of 33 electrodes were positioned according to the modified international 10/20 electrode placement system (Figure 2b ). Reference and ground electrodes were located at Fz and AFz, respectively. Impedance was minimized by massaging the skin with an EEG prepping gel (Nu-Prep gel; D.O. Weaver & Co., Aurora CO, USA), and electrode contact was optimized using a conductive gel (Onestep-Clear gel; H+H Medical Devices, D€ ulmen Germany).
EEG activity from 0 to 500 Hz was recorded with a Xltek recording system (EMU40EX; Natus Medical Inc., Ontario, Canada). Signals were digitized at a 1024 Hz sampling rate and a 16-bit resolution.
Clinical data collection
Demographics and clinical information were collected from electronic medical records. Anesthetic management and intraoperative events were recorded from the in-house Anesthesia Information Management System. etSEVO, endtidal nitrous oxide and carbon dioxide concentrations, heart rate, blood pressure, and oxygen saturation were downloaded from the anesthetic monitoring system (Dr€ ager Apollo; Draeger Medical Inc., Telford, PA, USA) in real-time at a 1 Hz sampling rate using ixTrend (ixcellence, Wildau, Germany).
Induction data
Tracheal intubation or laryngeal mask airway placement was recorded with a camcorder directed at the head, and time-locked to EEG (Xltek DSP270x; Natus Medical Inc).
EEG analysis
EEG preprocessing was carried out with Neuroworks (Natus Medical Inc). Ear electrodes (M1 & M2) were excluded from the final analysis due to poor surfaceto-skin contact. Each EEG recording was reviewed, and channels with noise or artifact were excluded. A discontinuous event was defined as: (i) amplitude <25 uV, (ii) observed across the majority of electrodes, and (iii) duration of 2 s or greater (3) . Discontinuity events were manually identified and extracted (L.C.). A subset of 34 EEG recordings (35%) were reviewed by a board-certified pediatric electroencephalographer (A.B.) to validate inter-rater reliability; there was 100% concordance between the two investigators' identification of discontinuity events.
Anesthetic management and clinical vital signs analysis
Anesthetic management variables included etSEVO and endtidal nitrous oxide concentrations, and propofol weight-scaled dosing. Clinical vital sign variables included noninvasive blood pressure (cycled every 5 min), heart rate (ECG), and estimated arterial oxygen saturation (pulse oximetry).
For children with discontinuity events
To analyze clinical vital signs immediately around a discontinuity event, epochs were taken at: (i) baseline (30-s period immediately before the start); (ii) during 
For all children
To analyze etSEVO during the course of anesthesia, epochs were taken at (i) induction (starting 5 min after sevoflurane initiation and ending 1 min before surgical incision); and (ii) maintenance ('etSEVO Maintenance ': 30-s period taken 10 min after incision), as well as (iii) discontinuity ('etSEVO Discontinuity ': defined in previous paragraph); (Figure 2) . The rationale for selecting these epochs was to conduct: (i) within-subject comparisons for subjects who had discontinuity events, and (ii) between-group comparisons among subjects with discontinuity events vs those without discontinuity events, over the period of interest.
Procedural event analysis
Video recordings were reviewed frame-by-frame to record times for tracheal intubation or laryngeal mask airway placement.
Outcome measures
Primary outcome measures were number of discontinuity events. Secondary outcome measures were duration of discontinuity events, demographic variables, clinical vital signs, procedural events and anesthetic dosing.
Statistics
Data are reported as median [95% confidence interval limits of median (95%CI)] unless otherwise stated. Data were tested for normality using a D'Agostino-Pearson omnibus test. Statistical analyses were performed using GRAPHPAD PRISM 7.0 (GraphPad Prism Software Inc., La Jolla CA, USA) and SPSS STATISTICS v23 (IBM Corp., Armonk NY, USA).
Children were divided into two groups posthoc: (i) those with discontinuity, and (ii) those with no discontinuity. To test the relationship between discontinuity events and age, and anesthetic management, betweengroup comparisons were made using Fisher's exact test, Welch's t-test (assuming unequal variance), or MannWhitney signed rank test. P < 0.05 was a significance threshold. To test the change over time in the duration Unpaired t-test with differences between the means determined. P < 0.05 considered statistically significant noted in bold type-face.
of discontinuity events, systemic physiology, and etSEVO, within-subject comparisons were made using Wilcoxon matched-pairs tests or Friedman repeated measures tests (followed by Dunn's posthoc multiple comparisons with a corrected P < 0.05). The relationship between number of discontinuity events and age at study was tested using Spearman's rank-order correlation. Discontinuity events were divided into two groups depending on the phase of anesthesia they appeared: (i) during induction and (ii) postsurgical incision. To test the relationship with etSEVO during discontinuity (etSEVO Discontinuity ), induction (etSEVO Induction ), or postsurgical incision (etSEVO Maintenance ), within-subject comparisons were made using Wilcoxon matched-pair tests. To establish the relationship with presence or absence of discontinuity, and overall etSEVO during each phase of anesthesia, between-group comparisons were made using Mann-Whitney signed rank test.
The presence or absence of discontinuity was evaluated using a logistic model with age and endtidal sevoflurane concentration as dependent variables.
Power analysis
The current study is a secondary analysis based on data from a study examining age-dependent EEG patterns during general anesthesia in children. The primary aim of the original study was to evaluate age-dependent appearance of alpha EEG oscillations during maintenance and emergence from sevoflurane anesthesia (14) .
Early in the course of the original study, we observed one or more discontinuity events in 65% subjects (13/ 20) . We sought to expand the study aims and prospectively planned to evaluate the incidence of discontinuity events as a secondary objective. Based on the interim analysis (65% incidence), an estimated sample size of 62 children was needed to establish the incidence of discontinuity events in at least 45% subjects, with 90% power and alpha of 0.05. We adjusted the targeted enrollment number to 82 children to account for a possible 33% data rejection rate; the final analysis included 68 children. Exploratory analyses investigating the association of discontinuity events with demographic and perioperative factors were performed posthoc.
Results
Continuous multichannel EEG recordings were reviewed for 82 children 0-40 months old. Sixty-eight children were included in the final analysis (Figure 1 ). Demographics and clinical characteristics are given for the cohort (Table 1 ) and individual children (Table S1) .
No children exhibited clinical signs of seizures or myoclonic movements, and no EEG was interpreted as seizure activity at any time.
Characteristics of discontinuity events
Incidence, duration, and inter-event interval Raw EEG review showed that discontinuity was present in 51.5% (35/68) of children between 0 and 40 months of age (Table 1) . Examples of discontinuity events are shown in Figure 2c ,d.
259 discontinuity events were observed in the EEGs of 35 children. In all cases, discontinuity appeared and resolved synchronously across all channels.
The time course of discontinuity events during anesthesia in individual subjects are shown in Figure 3a . Among children who had discontinuity events, the median number (n) of events was 4 (95%CI: 2-7; n subjects = 35) per child (Figure 4a ). Duration of discontinuity was 10 s (95%CI: 8-12 s; n events = 259; Figure 4b) . Discontinuity events were observed on multiple occasions in 77% subjects (27/35). The inter-event interval was 23 s (95%CI: 20-26 s).
Five subjects had at least one discontinuity event that lasted ≥5 min (Figures 3a and 4b ). All remained clinically stable throughout. None had a history of prematurity or other apparent remarkable features of the clinical history that might predispose to discontinuity events. All subjects recovered uneventfully postoperatively.
Discontinuity event duration over time
Duration of discontinuity in subjects who exhibited one event vs multiple discontinuity events was not significantly different [1 event: 96 s (95%CI: 11-232 s), n subjects = 9; Multiple events: 32 s (95%CI: 15-89 s), n subjects = 26; difference between medians: 64 s (95%CI: À21 to 115 s), P = 0.33, Mann-Whitney].
In a subcohort of 10 subjects who exhibited discontinuity events on ≥8 occasions, there were no within-subject differences in discontinuity duration over time [duration: 13 s (95%CI: 8-20 s); v 2 = 11.1, P = 0.14, Friedman].
Systemic physiology
Subjects appeared physiologically stable and they did not exhibit hypotension, hypo-, and hypercarbia during the events (Table S2) . For all subjects, blood pressure did not change post-versus prediscontinuity (Table S2) . There was a statistically significant, but clinically trivial, overall effect on heart rate (v 2 = 6.75, P = 0.03; Friedman) immediately around discontinuity events: medians differed by ≤3 beats per minute at successive time points (Table S2) . Oxygen saturation remained ≥98% before, during, and after a discontinuity event in 34/35 children. One subject had desaturation (86-90%) for <1 min during a discontinuity event at induction; saturation was otherwise >98% for the remainder of the case.
Perioperative time course of events
Time course of events including duration of anesthesia, time of intubation or laryngeal mask airway placement, and surgical incision in individual subjects are shown in Figure 3 . Discontinuity events started before surgical incision in 97.4% (34/35) subjects. The time to first discontinuity event was 11 min (95%CI: 7.9-14 min) after sevoflurane initiation.
Endotracheal tube or laryngeal mask airway placement was completed within a mean time of 13 min (95%CI: 11-16 min) after sevoflurane initiation. There were no significant differences in the time taken to complete ETT or laryngeal mask airway placement in subjects with discontinuity events compared to those with no discontinuity events [difference between means: 0.5 min (95%CI: À2.2 to 3.3 min), P = 0.7; Welch].
Discontinuity events occurred mostly during the first 30 min of anesthesia (66.4% of total events; 172/259 in 34 subjects). Few discontinuity events took place during maintenance (21.2% of total events; 55/259 in 13 subjects). No discontinuity events were observed during emergence. For all discontinuity events, median time to occurrence was 19 min (95%CI: 13-28 min; n events = 259) after sevoflurane initiation.
Age
Children who had discontinuity events were significantly younger (5.5 months, 95%CI: 3.6-6.5 months) compared to children who had no discontinuity events (10.2 months, 95%CI: 6.1-14 months); [difference between medians, 4.7 months (95%CI: 2.3-8 months), P = 0.0002, Mann-Whitney; Figure 4c ]. The incidence of discontinuity events was 82% (9/11) at <3 months, 61% (17/28) at 3-6 months, 50% (8/16) at 7-12 months, and decreased to 17% (1/6) at 13-18 months. Discontinuity was not observed at ≥19 months (0/7). Younger age was also correlated with a higher number of discontinuity events (r 68 = À0.53, P < 0.0001, Spearman; Figure 4b ).
Correlates of discontinuity events etSEVO etSEVO at the time of individual discontinuity events for each subject are shown in Figure 5a . During induction, median etSEVO Discontinuity was 3.6% (95%CI: 3.2-4.2%; n subjects = 34) and significantly higher compared to median etSEVO Induction , which was 2.9% (95%CI: 2.7-3.1%); [median of differences: 0.6% (95%CI: 0.3-1.4%), P < 0.0001, Wilcoxon (Figure 5b) ]. There were no differences in median etSEVO Induction in subjects with discontinuity compared to those with no discontinuity 
5.1-7%
4.1-5% 3.1-4% 2.1-3% <2% which was 2.7% (95%CI: 2.5-3.1%, n subjects = 34); [difference between medians: 0.2% (95%CI: À0.2% to 0.4%), P = 0.47, Mann-Whitney; Figure 5b ]. After surgical incision, etSEVO Discontinuity was statistically significantly greater, but to a clinically insignificant degree compared etSEVO Maintenance [etSEVO Discontinuity : 2.7% (95%CI: 2.6-3.2%; n subjects = 13) vs etSEVO Maintenance : 2.6% (95%CI: 1.9-3.2%)]; [median of differences: 0.1% (95%CI: 0-1.3%), P = 0.04, Wilcoxon (Figure 5c) ]. There were no group differences during maintenance: subjects with no discontinuity had a median etSEVO Maintenance of 2.6% (95%CI: 2.2-2.7%, n subjects = 55); [difference between medians: 0% (95% CI: À0.5% to 0.4%), P = 0.88, Mann-Whitney; Figure 5c] . No subjects exhibited discontinuity events during emergence.
Age and sevoflurane
Age was associated with discontinuity during anesthesia (Odds Ratio: 0.8, 95%CI: 0.7-0.9; P = 0.001; logistic model). etSEVO Induction was not found to be significantly associated with discontinuity (Odds Ratio: 1.1, 95%CI: 0.4-2.7; P = 0.86; logistic model).
General anesthetic management
Choice of anesthetic management technique varied according to the anesthesiologist. There were no differences between groups of children with and without discontinuity events in the use of nitrous oxide, propofol, opioids, local anesthesia, or regional anesthesia (Table 1) . Perioperative time course of anesthesia management medication administration for individual subjects is shown in Figure S1 . Propofol A propofol bolus was given to 47% of children (32/68; Table 1 ). Of the 32 children who were given propofol, 15 subjects exhibited discontinuity events within 30 min of propofol administration ( Figure S1 ). Based on these proportions, propofol administration was not a significant predictor of discontinuity events (P = 0.097; Fisher).
Among subjects who exhibited discontinuity events within 30 min of propofol administration, time to discontinuity event after a propofol bolus was 8.2 min (95%CI: 6.3-9.7 min; n subjects = 15). There were no significant differences in median propofol dose when discontinuity events were observed (1.6 mgÁkg À1 , 95%CI:
0.79-2 mgÁkg À1 ; n subjects = 15) compared to when no discontinuity events were observed (1.2 mgÁkg 
Discussion
We used multi-electrode EEG recordings to characterize discontinuity events in 68 children 0-40 months of age during sevoflurane general anesthesia. We show that discontinuity events: (i) frequently appear (Figures 3 and  4a,b) ; (ii) are more common in younger infants (Figure 4c,d) ; (iii) occur without evidence of systemic physiologic impairments (Table S2) ; and (iv) generally occur within the first 30 min of induction, at relatively high etSEVO (<3%), and before surgical incision ( Figure 5 ). Discontinuity events were not strongly related to prior dosing of propofol, administration of nitrous oxide, opioids, or regional or local anesthesia (Table 1) .
neurocognitive sequelae (15, 16) . In contrast, most, but not all, of the events observed here involve 'suppression without burst'. In infants, EEG discontinuity is an abnormal finding, and is associated with critical illness such as encephalopathy (1, 3) or complex congenital heart surgery (4), and is associated with adverse neurological outcome (5). However, long-term consequences of discontinuity events during general anesthesia in children regarding neurological and neurodevelopmental outcomes remain unknown.
Infant animal studies of EEG discontinuity and burst suppression during general anesthesia
Intracortical EEG recordings in infant rats anesthetized with volatile anesthetics (i.e., isoflurane) show agedependent suppression of cortical activity in a concentration-dependent manner (17, 18) . In the first week of life (akin to term age in human years), cortical activity is completely suppressed by 1.5-2% inspired isoflurane and is less effectively suppressed at 2 weeks of age or in adulthood.
Study limitations and constraints
Anesthetic management reflected prevailing practice among several anesthesiologists and was not standardized. While the anesthetic management protocol was not changed to accommodate the research protocol, there was no way to blind the anesthesiologist from seeing the EEG cap and knowing the patient was enrolled in the study. Multiple anesthesia providers were responsible for anesthesia in the patients included in this study, with a range of fellows, residents, and nurse anesthetists. There is potential for the anesthesiologist to use a different amount of anesthetic gas or adapt their technique if they were aware of being observed. Future studies incorporating control subjects would permit comparison of anesthetic technique in a nonresearch setting. Additionally, as a posthoc exploratory analysis, interpretations of these data should be regarded as somewhat provisional.
Clinical implications and future directions
Titration of anesthetic depth in infants remains challenging. Concerns around potential neurodevelopmental sequelae of general anesthetics are a major issue for the field of pediatric anesthesiology; potential confounders have been discussed elsewhere (19, 20) . Recent casecontrol studies such as the Pediatric Anesthesia NeuroDevelopment Assessment study, interim analysis of one large prospective study (GAS), and clinical metaanalyses have been more reassuring (21) (22) (23) (24) . Based on infant animal studies, and previous case-control series, the potential risk might possibly increase with duration of exposure and anesthetic dose (17) (18) (19) .
The current study involved current practice among pediatric anesthesiologists without an attempt to dictate decisions about selection among agents and techniques. Most cases involved tracheal intubation or laryngeal mask airway facilitated by use of high etSEVO (commonly >3%) and/or bolus administration of propofol, most without use of neuromuscular blockade. To the extent that discontinuity events might be a clinical sign of an 'overanesthetized brain', it raises the question of whether alternative approaches should be considered for airway instrumentation instead of high concentrations of sevoflurane or propofol. At present, it is purely a speculation that alternative approaches would reduce the frequency of discontinuity events and/or provide reduced risk of neurodevelopmental sequelae. Such an association would require evaluation in future prospective studies.
In summary, discontinuity events were frequently observed in the EEG of young infants at clinically relevant sevoflurane concentrations >3%. Discontinuity events occurred less often following surgical incision and were absent during emergence from anesthesia. Their implications for brain homeostasis and potential future use as a biomarker deserve further study.
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